FilingReader Intelligence
CSPC Innovation swings to loss despite revenue growth
August 15, 2025 at 01:09 PM UTC•By FilingReader AI
CSPC Innovation Pharmaceutical reported operating revenue of RMB1.05 billion for the six months ended June 30, 2025, up 7.99% from the prior year.
However, net profit attributable to shareholders declined 102%, resulting in a loss of RMB2.7 million. Earnings per share fell 102.05% to -RMB0.0020.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1093•Hong Kong Exchange
News Alerts
Get instant email alerts when CSPC Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime